Difference between revisions of "TC99m Biomarker Committee"
Jump to navigation
Jump to search
| Line 12: | Line 12: | ||
*[[Media:2019_04-09_QIBA_SPECT_TC99M_Call Summary-FINAL.post-Moz.pdf | April 9, 2019]] | *[[Media:2019_04-09_QIBA_SPECT_TC99M_Call Summary-FINAL.post-Moz.pdf | April 9, 2019]] | ||
*[[Media:2019_03-12_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | March 12, 2019]] | *[[Media:2019_03-12_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | March 12, 2019]] | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
'''''[[SPECT TC99m BC Call Summaries Archive]]''''' | '''''[[SPECT TC99m BC Call Summaries Archive]]''''' | ||
Revision as of 14:21, 3 July 2019
- Co-chairs: Yuni Dewaraja, PhD; Robert Miyaoka, PhD
- RSNA Staff Support: Julie Lisiecki
Full name of biomarker committee: Technetium-99m for body, oncology, and immunology
Recent Meetings/Call Summaries
SPECT TC99m BC Call Summaries Archive